FOR THE LATEST DEVELOPING NEWS Click Here
Enrollment Locations for Open Label Extension (OLE)
Investment Community Webcast - Wednesday, September 8
Brazil has approved critically ill COVID Phase 3 to begin
Leronlimab COVID-19 Brazil Trial enrolled the first patient
Leronlimab’s Mechanism of Action in COVID-19 Published
Experimental Drugs Aim to Treat Long-Haul Covid Patients
Leronlimab Published in Journal of Translational Autoimmunity
Dr. Seethamraju - Special isirv-AVG Virtual Conference
Leronlimab Potential in HIV PrEP
CytoDyn presents to large gathering of medical staff in different hospitals in Philippines
Long-Hauler Trial Endpoints
Oncology Presentation
Emerging Growth Conference – September 15
ANVISA Just Approved the Initiation of CD17 Leronlimab Phase 3 Trial
CD15 Patients’ Testimonies
